Amplify Weight Loss Drug & Treatment ETF Rating $22.92 +0.16 (+0.70%) As of 08/29/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.57Holdings in THNR have an aggregate rating of Moderate Buy based on 219 analyst ratings issued in the past year covering 12 companies (69.7% of the portfolio).THNR Aggregate Price Target$22.92High Prediction$22.92Average Prediction$22.92Low Prediction$22.92Holdings in THNR have an aggregate price target of $22.92 and a range of $22.92 to $22.92 covering 12 companies (69.7% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 12 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.28%LLYEli Lilly and Company$732.41+0.1%5 of 5 stars2.67$950.17 29.7%24Trending NewsAnalyst UpgradeAnalyst Revision8.44%NVONovo Nordisk A/S$56.51+0.7%4.578 of 5 stars2.13$81.00 43.4%16Trending News7.73%REGNRegeneron Pharmaceuticals$580.70+0.2%4.7849 of 5 stars2.81$817.67 40.8%27Trending NewsAnalyst Forecast6.94%AMGNAmgen$287.71+0.7%4.5628 of 5 stars2.33$304.43 5.8%21Trending NewsAnalyst Revision5.61%ABBVAbbVie$210.25+1.1%4.7595 of 5 stars2.92$214.95 2.2%26Trending News5.51%AZNAstraZeneca$79.90-0.1%2.9131 of 5 stars2.80$86.00 7.6%5News CoveragePositive News5.51%GILDGilead Sciences$112.97+0.4%4.9664 of 5 stars2.88$115.39 2.1%26Positive NewsInsider Trade5.38%MRKMerck & Co., Inc.$84.13+1.1%4.9963 of 5 stars2.35$107.44 27.7%20News CoveragePositive News5.29%PFEPfizer$24.74+0.6%4.7834 of 5 stars2.39$28.12 13.7%18Positive News3.39%HIMSHims & Hers Health$42.36-4.0%3.2243 of 5 stars1.92$38.92 -8.1%13Insider Trade2.86%VKTXViking Therapeutics$27.05-1.9%3.8858 of 5 stars3.00$86.92 221.3%14Analyst Revision1.74%CRNXCrinetics Pharmaceuticals$30.99+1.1%3.6307 of 5 stars2.78$68.86 122.2%9News CoveragePositive NewsInsider Trade This page (NYSEARCA:THNR) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
